Today, a growing body of evidence points to the immunogenicity of breast tumours and the role of antitumor immunity in the biology of these tumours, highlighting the importance of immune evasion mechanisms, including the PDL-1/PD1 axis [48,49]. This evidence concerns the gene CD274 and neoplasm.